Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Inventory (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Inventory for 10 consecutive years, with $228.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 92.64% year-over-year to $228.8 million, compared with a TTM value of $228.8 million through Dec 2025, up 92.64%, and an annual FY2025 reading of $228.8 million, up 92.64% over the prior year.
  • Inventory was $228.8 million for Q4 2025 at Amicus Therapeutics, up from $177.9 million in the prior quarter.
  • Across five years, Inventory topped out at $228.8 million in Q4 2025 and bottomed at $13.3 million in Q3 2022.
  • Average Inventory over 5 years is $72.0 million, with a median of $54.2 million recorded in 2023.
  • The sharpest move saw Inventory plummeted 39.87% in 2022, then skyrocketed 328.99% in 2023.
  • Year by year, Inventory stood at $26.8 million in 2021, then decreased by 11.19% to $23.8 million in 2022, then soared by 150.66% to $59.7 million in 2023, then skyrocketed by 98.98% to $118.8 million in 2024, then soared by 92.64% to $228.8 million in 2025.
  • Business Quant data shows Inventory for FOLD at $228.8 million in Q4 2025, $177.9 million in Q3 2025, and $154.9 million in Q2 2025.